Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma

(2011) M Miyamoto et al.   BRITISH JOURNAL OF CANCER

Molecular prediction of early recurrence after resection of hepatocellular carcinoma

(2009) Shinichi Yoshioka et al.   EUROPEAN JOURNAL OF CANCER

IncreasedMETGene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

(2009) Federico Cappuzzo et al.   JOURNAL OF CLINICAL ONCOLOGY

Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma

(2009) Uma Krishnamurti et al.   MODERN PATHOLOGY

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients

(2008) F. Cappuzzo et al.   ANNALS OF ONCOLOGY

Targeting the c-MET signaling pathway for cancer therapy

(2008) Xiangdong Liu et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma

(2008) Ai-Wu Ke et al.   HEPATOLOGY

Drug development of MET inhibitors: targeting oncogene addiction and expedience

(2008) Paolo M. Comoglio et al.   NATURE REVIEWS DRUG DISCOVERY